Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis...
35 KB (3,270 words) - 15:33, 10 October 2024
been explored, including immunomodulatory agents such as imiquimod. Tofacitinib citrate may also have benefits. In June 2014, a 25-year-old man with...
11 KB (1,130 words) - 10:21, 11 October 2024
transcription. The first JAK inhibitor to reach clinical trials was tofacitinib. Tofacitinib is a specific inhibitor of JAK3 (IC50 = 2 nM) thereby blocking...
37 KB (3,296 words) - 02:08, 8 November 2024
current generic equivalent available on the market. The JAK1 inhibitors tofacitinib (Xeljanz) and upadacitinib (Rinvoq) are approved for the use in active...
32 KB (3,440 words) - 01:34, 28 October 2024
colitis, myeloid metaplasia with myelofibrosis and vitiligo. Examples are tofacitinib, baricitinib, upadacitinib and filgotinib. In 2014 researchers discovered...
9 KB (974 words) - 14:46, 22 June 2024
gene expression in immunological cells. Other JAK inhibitors include tofacitinib, which is indicated for the treatment of rheumatoid arthritis, psoriatic...
43 KB (3,613 words) - 18:17, 17 November 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
26 KB (2,676 words) - 11:45, 12 November 2024
neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin. BEACON Medicare Limited(BML) is the exclusive global...
5 KB (232 words) - 10:23, 8 March 2024
The US Food and Drug Administration (FDA) requires a boxed warning for tofacitinib, baricitinib, and upadacitinib to include information about the risks...
46 KB (4,534 words) - 15:25, 4 November 2024
availability of TNF inhibitors and other agents, such as tocilizumab and tofacitinib. Penicillamine works by reducing numbers of T-lymphocytes, inhibiting...
16 KB (1,390 words) - 07:56, 12 November 2024